Liposomal Bupivacaine with Bupivacaine — Competitive Intelligence Brief

Liposomal Bupivacaine with Bupivacaine (Liposomal Bupivacaine with Bupivacaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia / Pain Management.

phase 3 Local anesthetic Voltage-gated sodium channels Anesthesia / Pain Management Small molecule

Target snapshot

Liposomal Bupivacaine with Bupivacaine (Liposomal Bupivacaine with Bupivacaine) — Jamaica Hospital Medical Center. Liposomal bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, with the liposomal formulation providing prolonged drug release and extended anesthesia duration.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Liposomal Bupivacaine with Bupivacaine TARGET	Liposomal Bupivacaine with Bupivacaine	Jamaica Hospital Medical Center	phase 3	Local anesthetic	Voltage-gated sodium channels
Prilocaine (Hyperbaric 2%)	Prilocaine (Hyperbaric 2%)	Guy's and St Thomas' NHS Foundation Trust	marketed	Local anesthetic	Voltage-gated sodium channels
Levobupivacaine epidural bolus	Levobupivacaine epidural bolus	University of Genova	marketed	Local anesthetic (amino amide)	Voltage-gated sodium channels
Generic lamotrigine	Generic lamotrigine	University of Maryland, Baltimore	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
Lacosamide - rapid titration 2	Lacosamide - rapid titration 2	Seoul National University Hospital	marketed	Anticonvulsant; sodium channel modulator	Voltage-gated sodium channels; CRMP-2
Carbamazepine-Implant	Carbamazepine-Implant	University of Sao Paulo	marketed	Anticonvulsant / Antiepileptic agent	Voltage-gated sodium channels
Levobupivacaine PCA group	Levobupivacaine PCA group	Osijek University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

1. University of California, San Diego · 3 drugs in this class
2. Durect · 3 drugs in this class
3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
4. Wake Forest University Health Sciences · 3 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Imperial College London · 2 drugs in this class
7. Hvidovre University Hospital · 2 drugs in this class
8. Innocoll · 2 drugs in this class
9. George Washington University · 2 drugs in this class
10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class